Can a person infected with anthrax be cured?
Yes. The survivability rate of a person infected with anthrax through either the cutaneous or gastrointestinal form of the infection, if caught early, is promisingly high. Antibiotics, such as ciprofloxacin (Cipro, manufactured by Bayer who currently holds the patent), doxycycline or penicillin, are used to treat the infected person for a period of about sixty (60) days to allow all of the anthrax spores to germanate and die. Treatment with antibiotics has a greater success rate if started prior to the onset of symptoms and includes an anthrax vaccination prior to discontinuing the prescribed antibiotics. If the person was infected through inhalation and anthrax lodges deep into the person’s lungs, the survivability rate is relatively low. A delay in the use of antibiotics lessens the infected person’s chances for survival.
